Regina Brown
2023
In 2023, Regina Brown earned a total compensation of $78.1K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 16% decrease compared to previous year.
Compensation breakdown
| Option Awards | $48,131 |
|---|---|
| Other | $30,000 |
| Total | $78,131 |
Brown received $48.1K in option awards, accounting for 62% of the total pay in 2023.
Brown also received $30K in other compensation.
Rankings
In 2023, Regina Brown's compensation ranked 2,724th out of 2,790 executives tracked by ExecPay. In other words, Brown earned more than 2.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,724 out of 2,790 | 2nd |
Division Manufacturing | 1,506 out of 1,530 | 2nd |
Major group Chemicals And Allied Products | 855 out of 869 | 2nd |
Industry group Drugs | 819 out of 832 | 2nd |
Industry Pharmaceutical Preparations | 587 out of 597 | 2nd |
Source: SEC filing on November 4, 2024.
Brown's colleagues
We found four more compensation records of executives who worked with Regina Brown at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.